Farnesoid X receptor ligand CDCA suppresses human prostate cancer cells growth by inhibiting lipid metabolism via targeting sterol response element binding protein 1.

Liu, Nian; Zhao, Jun; Wang, Jinguo; Teng, Haolin; Fu, Yaowen; Yuan, Hang

Liu, Nian; Zhao, Jun; Wang, Jinguo; Teng, Haolin; Fu, Yaowen; Yuan, Hang.

Afiliação

Liu N; Department of Urology, The First Hospital of Jilin University Changchun, Jilin Province 130021, China.
Zhao J; Department of Urology, The First Hospital of Jilin University Changchun, Jilin Province 130021, China.
Wang J; Department of Urology, The First Hospital of Jilin University Changchun, Jilin Province 130021, China.
Teng H; Department of Urology, The First Hospital of Jilin University Changchun, Jilin Province 130021, China.
Fu Y; Department of Urology, The First Hospital of Jilin University Changchun, Jilin Province 130021, China.
Yuan H; Department of Nephrology, The First Hospital of Jilin University Changchun, Jilin Province 130021, China.

Am J Transl Res ; 8(11): 5118-5124, 2016.

Article em En | MEDLINE | ID: mdl-27904713

Palavras-chave

FXR; Prostate cancer; SREBP1; lipogenesis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Transl Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google